I agree. Moreover, management could have fielded questions on this matter by shareholders which prompt them to release this announcement so that all its shareholders are informed, rather than a select few.
What I like most is this: can be used by care staff to assess pain on residents from up to 3 meters distance supporting existing RAC infection control strategies
That is a great selling point in this viral environment. In fact, I believe that this very point, and the fact that these facilities still need to manage its residents' pain, that could well promote the sales of PainChek into those facilities that are experiencing staff fear of infection.
